Life
Briefing: Trump Administration Plans 100% Tariff on Patented Medicines
Strategic angle: The FDA approves a new obesity pill from Lilly amidst tariff discussions.
Editorial Staff 15 days ago
2 articles tagged with "Lilly"
Strategic angle: The FDA approves a new obesity pill from Lilly amidst tariff discussions.
It's the third time in recent weeks that the FDA has admonished Novo Nordisk for different practices.